Login to Your Account

Financings Roundup

Lpath Moving Sphingomab Into Clinic With $16.8M Financing

By Jennifer Boggs

Monday, June 18, 2007
Lpath Inc. closed the second tranche of an April private placement, for a total financing of $16.8 million to push its lead compound, the anti-angiogenic compound Sphingomab, into the clinic.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription